Additionally, the stock sold off after its fourth-quarter earnings report in late February as investors looked past the company's 145% revenue growth, which was helped by its acquisition of Livongo Health last year. On an adjusted EBITDA basis, the company reported a profit of $50.4 million, compared to $15.2 million for the fourth quarter of 2019. Read More...
Additionally, the stock sold off after its fourth-quarter earnings report in late February as investors looked past the company’s 145% revenue growth, which was helped by its acquisition of Livongo Health last year. On an adjusted EBITDA basis, the company reported a profit of $50.4 million, compared to $15.2 million for the fourth quarter of 2019.
Add Comment